(Q37321010)

19 August 2017

1 reference

title

Molecular imaging of renal cell carcinoma (English)

1 reference

19 August 2017

Rodolfo Perini

1

1 reference

19 August 2017

Daniel Pryma

series ordinal

2

1 reference

19 August 2017

Chaitanya Divgi

series ordinal

3

1 reference

19 August 2017

publication date

1 November 2008

1 reference

Urologic Clinics of North America

19 August 2017

published in

1 reference

19 August 2017

volume

35

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

605-11; vi

1 reference

How I do it: evaluating renal masses

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Problems in the detection and characterization of small renal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Preoperative nomogram predicting 12-year probability of metastatic renal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Predicting the histology of renal masses using preoperative Doppler ultrasonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Solid renal cortical tumors: differentiation with CT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Cross-sectional imaging evaluation of renal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Cancer's molecular sweet tooth and the Warburg effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Quantitative assessment of tumor metabolism using FDG-PET imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Positron-emission tomography and assessment of cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Molecular positron emission tomography and PET/CT imaging in urological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

FDG PET characterization of renal masses: preliminary experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Validation of renal oxidative metabolism measurement by positron-emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

PET imaging with 11C-acetate in prostate cancer: a biochemical, radiochemical and clinical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Renal oncocytoma on 1-11C acetate positron emission tomography: Case report and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

[1-(11)C]acetate uptake is not increased in renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Molecular imaging of proliferation in malignant lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

The roles of PET and PET/CT in the diagnosis and management of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Choline metabolism in cancer: implications for diagnosis and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

An immunohistochemical approach to the differential diagnosis of renal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Active and passive immunotherapy: vaccines and antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Monoclonal antibody-based therapy for renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Surgery insight: advances in techniques for open partial nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.015

10.1016/J.UCL.2008.07.015

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference